Farmaceutica Remedia (stock symbol: RMAH), one of the leading players on the drug wholesale market, ended 2024 with net profit of RON7 million, down 2.8% against a net result of RON7.2 million reported in 2023, as per data from the company's annual preliminary financial report sent to the Bucharest Stock Exchange.